Ramsay Générale de Santé Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
Pascal Roche
Chief executive officer
€1.4m
Total compensation
CEO salary percentage | 44.8% |
CEO tenure | 13.5yrs |
CEO ownership | n/a |
Management average tenure | 4.8yrs |
Board average tenure | 5yrs |
Recent management updates
Recent updates
We Think Ramsay Générale de Santé SA's (EPA:GDS) CEO Compensation Package Needs To Be Put Under A Microscope
Dec 06Is Ramsay Générale de Santé (EPA:GDS) Using Too Much Debt?
Oct 28Ramsay Générale de Santé SA (EPA:GDS) Could Be Riskier Than It Looks
Oct 02Returns On Capital At Ramsay Générale de Santé (EPA:GDS) Paint A Concerning Picture
May 29Many Still Looking Away From Ramsay Générale de Santé SA (EPA:GDS)
May 03Ramsay Générale de Santé (EPA:GDS) Seems To Be Using A Lot Of Debt
Mar 29Investors Interested In Ramsay Générale de Santé SA's (EPA:GDS) Earnings
Jan 23Ramsay Générale de Santé (EPA:GDS) Has A Somewhat Strained Balance Sheet
Oct 26Ramsay Générale de Santé (EPA:GDS) Is Reinvesting At Lower Rates Of Return
Oct 05Does Ramsay Générale de Santé (EPA:GDS) Deserve A Spot On Your Watchlist?
Aug 09We Think Ramsay Générale de Santé (EPA:GDS) Is Taking Some Risk With Its Debt
Jun 16The Returns At Ramsay Générale de Santé (EPA:GDS) Aren't Growing
May 27Is Now The Time To Put Ramsay Générale de Santé (EPA:GDS) On Your Watchlist?
May 06Is Ramsay Générale de Santé (EPA:GDS) Using Too Much Debt?
Mar 15Returns On Capital At Ramsay Générale de Santé (EPA:GDS) Have Stalled
Feb 23Does Ramsay Générale de Santé (EPA:GDS) Deserve A Spot On Your Watchlist?
Jan 03Slowing Rates Of Return At Ramsay Générale de Santé (EPA:GDS) Leave Little Room For Excitement
Nov 19Here's Why We Think Ramsay Générale de Santé (EPA:GDS) Is Well Worth Watching
Sep 13Ramsay Générale de Santé (EPA:GDS) Has Some Way To Go To Become A Multi-Bagger
Aug 09Here's Why I Think Ramsay Générale de Santé (EPA:GDS) Is An Interesting Stock
Jun 02Return Trends At Ramsay Générale de Santé (EPA:GDS) Aren't Appealing
Mar 29If You Like EPS Growth Then Check Out Ramsay Générale de Santé (EPA:GDS) Before It's Too Late
Feb 01Slowing Rates Of Return At Ramsay Générale de Santé (EPA:GDS) Leave Little Room For Excitement
Dec 05Here's Why We Think Ramsay Générale de Santé (EPA:GDS) Is Well Worth Watching
Oct 30Is Ramsay Générale de Santé (EPA:GDS) A Risky Investment?
Oct 11Ramsay Générale de Santé (EPA:GDS) Will Want To Turn Around Its Return Trends
Aug 31If You Like EPS Growth Then Check Out Ramsay Générale de Santé (EPA:GDS) Before It's Too Late
Jul 15These 4 Measures Indicate That Ramsay Générale de Santé (EPA:GDS) Is Using Debt Extensively
Jun 15Ramsay Générale de Santé (EPA:GDS) Will Will Want To Turn Around Its Return Trends
May 04We Think Ramsay Générale de Santé (EPA:GDS) Is Taking Some Risk With Its Debt
Mar 08Should We Be Cautious About Ramsay Générale de Santé SA's (EPA:GDS) ROE Of 1.7%?
Feb 15Should We Be Excited About The Trends Of Returns At Ramsay Générale de Santé (EPA:GDS)?
Jan 19Should Ramsay Générale de Santé (EPA:GDS) Be Disappointed With Their 19% Profit?
Dec 23Here's Why Ramsay Générale de Santé's (EPA:GDS) Statutory Earnings Are Arguably Too Conservative
Dec 03CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Jun 30 2024 | €1m | €640k | -€54m |
Mar 31 2024 | n/a | n/a | -€10m |
Dec 31 2023 | n/a | n/a | -€12m |
Sep 30 2023 | n/a | n/a | €19m |
Jun 30 2023 | €1m | €610k | €49m |
Mar 31 2023 | n/a | n/a | €69m |
Dec 31 2022 | n/a | n/a | €103m |
Sep 30 2022 | n/a | n/a | €111m |
Jun 30 2022 | €1m | €610k | €118m |
Mar 31 2022 | n/a | n/a | €98m |
Dec 31 2021 | n/a | n/a | €77m |
Sep 30 2021 | n/a | n/a | €71m |
Jun 30 2021 | €1m | €610k | €65m |
Mar 31 2021 | n/a | n/a | €63m |
Dec 31 2020 | n/a | n/a | €61m |
Sep 30 2020 | n/a | n/a | €37m |
Jun 30 2020 | €612k | €610k | €13m |
Mar 31 2020 | n/a | n/a | €11m |
Dec 31 2019 | n/a | n/a | €8m |
Sep 30 2019 | n/a | n/a | €8m |
Jun 30 2019 | €1m | €560k | €8m |
Compensation vs Market: Pascal's total compensation ($USD1.48M) is about average for companies of similar size in the French market ($USD1.49M).
Compensation vs Earnings: Pascal's compensation has increased whilst the company is unprofitable.
CEO
Pascal Roche (62 yo)
13.5yrs
Tenure
€1,428,599
Compensation
Mr. Pascal Roche has been the Chairman of the Board and Chief Executive Officer of Capio AB (publ) since December 4, 2018. Mr. Roche has been the Chief Executive Officer at Ramsay Générale de Santé SA sinc...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Chief Executive Officer | 13.5yrs | €1.43m | no data | |
Director of Group Investments and Risks | 5.8yrs | no data | no data | |
Head of Investor Relations | no data | no data | no data | |
Group Legal Director & Secretary of the Board of Director | 3.8yrs | no data | no data | |
Group Communication | 3.3yrs | no data | no data |
4.8yrs
Average Tenure
Experienced Management: GDS's management team is considered experienced (4.8 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Director | 9.8yrs | €55.00k | no data | |
Chairman | 10.2yrs | €47.50k | no data | |
Independent Director | 10.8yrs | €55.00k | no data | |
Director | 3.8yrs | €45.00k | no data | |
Director | 4.7yrs | €45.00k | no data | |
Director | 9.5yrs | €45.00k | no data | |
Employee Representative Director | 5.3yrs | €35.00k | no data | |
Employee Representative Director | 3.5yrs | €35.00k | 0.000010% € 126.4 | |
Director | less than a year | no data | no data | |
Vice Chairman | 2.7yrs | no data | no data |
5.0yrs
Average Tenure
57.5yo
Average Age
Experienced Board: GDS's board of directors are considered experienced (5 years average tenure).
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/24 20:21 |
End of Day Share Price | 2024/12/24 00:00 |
Earnings | 2024/06/30 |
Annual Earnings | 2024/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Ramsay Générale de Santé SA is covered by 4 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Frederic Caumon | Deutsche Bank |
Murielle Andre-Pinard | HSBC |
Cédric Moreau | Natixis S.A. |